Suppr超能文献

角质层胶带剥离法:使用局部治疗对特应性皮炎患者炎症介质的监测

Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy.

作者信息

Koppes Sjors A, Brans Richard, Ljubojevic Hadzavdic Suzana, Frings-Dresen Monique H W, Rustemeyer Thomas, Kezic Sanja

机构信息

Coronel Institute of Occupational Health, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

出版信息

Int Arch Allergy Immunol. 2016;170(3):187-93. doi: 10.1159/000448400. Epub 2016 Sep 2.

Abstract

OBJECTIVE

The aim of this study was to explore the tape strip sampling technique in the assessment of stratum corneum levels of inflammatory mediators in a clinical trial setting.

METHODS

Thirty-eight inflammatory mediators were analyzed by a multiplex-assay in the stratum corneum, collected by adhesive tapes before and after 6 weeks of therapy, in mild and moderate atopic dermatitis (AD) patients (n = 90). Treatment was a ceramide- and magnesium-containing emollient.

RESULTS

Twenty-four mediators could quantitatively be determined. The Th2 mediators interleukin (IL)-4, IL-13, CCL2 (monocyte chemotactic protein-1), CCL22 (macrophage-derived chemokine), and CCL17 [thymus and activation-regulated chemokine (TARC)] were significantly decreased after therapy as well as IL-1β, IL-2, IL-8 (CXCL8), IL-10, acute-phase protein serum amyloid A, C-reactive protein, and vascular adhesion molecule-1. The decrease of CCL17 and IL-8 was correlated with the decrease in disease severity in a subgroup of moderate AD individuals.

CONCLUSION

Stratum corneum tape stripping offers a minimally invasive approach for studying local levels of immunomodulatory molecules in the skin. CCL17 (TARC) and IL-8 were found to be the most promising biomarkers of AD and might be useful for investigating the course of skin diseases and the effect of local therapy.

摘要

目的

本研究旨在探讨胶带条采样技术在临床试验环境中评估角质层炎症介质水平的应用。

方法

采用多重分析法对90例轻度和中度特应性皮炎(AD)患者在治疗前和治疗6周后通过胶带收集的角质层中的38种炎症介质进行分析。治疗药物为含神经酰胺和镁的润肤剂。

结果

可定量测定24种介质。治疗后,Th2介质白细胞介素(IL)-4、IL-13、CCL2(单核细胞趋化蛋白-1)、CCL22(巨噬细胞衍生趋化因子)和CCL17[胸腺和活化调节趋化因子(TARC)]以及IL-1β、IL-2、IL-8(CXCL8)、IL-10、急性期蛋白血清淀粉样蛋白A、C反应蛋白和血管黏附分子-1均显著降低。在中度AD患者亚组中,CCL17和IL-8的降低与疾病严重程度的降低相关。

结论

角质层胶带剥离为研究皮肤中免疫调节分子的局部水平提供了一种微创方法。发现CCL17(TARC)和IL-8是AD最有前景的生物标志物,可能有助于研究皮肤病的病程和局部治疗效果。

相似文献

1
Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy.
Int Arch Allergy Immunol. 2016;170(3):187-93. doi: 10.1159/000448400. Epub 2016 Sep 2.
2
Cytokine concentration across the stratum corneum in atopic dermatitis and healthy controls.
Sci Rep. 2020 Dec 14;10(1):21895. doi: 10.1038/s41598-020-78943-6.
3
Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skin.
Ann Allergy Asthma Immunol. 2021 Jan;126(1):46-53.e2. doi: 10.1016/j.anai.2020.08.397. Epub 2020 Sep 5.
4
A minimally invasive tool to study immune response and skin barrier in children with atopic dermatitis.
Br J Dermatol. 2019 Mar;180(3):621-630. doi: 10.1111/bjd.16994. Epub 2018 Oct 14.
5
Comparison of Cytokines in Skin Biopsies and Tape Strips from Adults with Atopic Dermatitis.
Dermatology. 2021;237(6):940-945. doi: 10.1159/000514308. Epub 2021 May 10.
6
Interleukin-8 Levels in the Stratum Corneum as a Biomarker for Monitoring Therapeutic Effect in Atopic Dermatitis Patients.
Int Arch Allergy Immunol. 2021;182(7):592-606. doi: 10.1159/000512965. Epub 2021 Jan 22.
8
The stratum corneum transcriptome in atopic dermatitis can be assessed by tape stripping.
J Dermatol Sci. 2021 Jan;101(1):14-21. doi: 10.1016/j.jdermsci.2020.10.011. Epub 2020 Oct 24.
10

引用本文的文献

1
Enabling precision medicine with biomarkers of response to treatment in atopic dermatitis: where are we now? A narrative review.
Front Med (Lausanne). 2025 Apr 10;12:1574697. doi: 10.3389/fmed.2025.1574697. eCollection 2025.
3
What is "eczema"?
J Dermatol. 2025 Feb;52(2):192-203. doi: 10.1111/1346-8138.17439. Epub 2024 Sep 20.
6
Tape Stripping - Searching for Minimally Invasive Biomarkers in Atopic Dermatitis.
Dermatol Pract Concept. 2024 Apr 1;14(2):e2024123. doi: 10.5826/dpc.1402a123.
7
Cytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review.
Cells. 2023 Dec 8;12(24):2793. doi: 10.3390/cells12242793.
10
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis.
Am J Clin Dermatol. 2023 Sep;24(5):753-764. doi: 10.1007/s40257-023-00793-5. Epub 2023 Jun 2.

本文引用的文献

3
Biomarkers for atopic dermatitis: a systematic review and meta-analysis.
Curr Opin Allergy Clin Immunol. 2015 Oct;15(5):453-60. doi: 10.1097/ACI.0000000000000198.
4
Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin.
J Eur Acad Dermatol Venereol. 2015 Nov;29(11):2136-44. doi: 10.1111/jdv.13160. Epub 2015 May 18.
5
A panel of biomarkers for disease severity in atopic dermatitis.
Clin Exp Allergy. 2015 Mar;45(3):698-701. doi: 10.1111/cea.12486.
6
Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
J Allergy Clin Immunol. 2014 Dec;134(6):1293-1300. doi: 10.1016/j.jaci.2014.10.013.
7
Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
N Engl J Med. 2014 Jul 10;371(2):130-9. doi: 10.1056/NEJMoa1314768.
9
Receptors, cells and circuits involved in pruritus of systemic disorders.
Biochim Biophys Acta. 2014 Jul;1842(7):869-92. doi: 10.1016/j.bbadis.2014.02.007. Epub 2014 Feb 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验